Active Biotech AB (publ) (STO:ACTI)
Sweden · Delayed Price · Currency is SEK 5.22
+0.12 (2.35%)
Jul 24, 2026, 5:18 PM CET
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 134.44 million as of July 24, 2026. Its market cap has decreased by -47.96% in one year.
Market Cap
134.44M
Enterprise Value
81.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.22
ChartMarket Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has increased from 6.93M to 134.44M, an increase of 1,839.85%. That is a compound annual growth rate of 11.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 137.60M | 13.48% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IRLAB Therapeutics AB | 189.46M |
| Elicera Therapeutics AB | 175.52M |
| Simris Group AB (PUBL) | 174.12M |
| Initiator Pharma | 167.03M |
| Xintela AB | 162.78M |
| Diamyd Medical AB | 162.42M |
| Alzinova AB | 151.98M |
| Nanologica AB | 144.00M |